Trademark Overview
On Monday, March 18, 2024, a trademark application was filed for UNIMYET with the United States Patent and Trademark Office. The USPTO has given the UNIMYET trademark a serial number of 98454125. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, September 26, 2024. This trademark is owned by LTZ Therapeutics Inc.. The UNIMYET trademark is filed in the Pharmaceutical Products category with the following description:
Medicines for human purposes for the treatment of cancer, autoimmune, and infectious diseases; biochemical medicines for the treatment of cancer, autoimmune, and infectious diseases; biological preparations for medical purposes for the treatment of cancer, autoimmune, and infectious diseases; pharmaceutical preparations for the treatment of autoimmune disorders, cancer, and infection; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer, autoimmune, and infectious diseases